Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deracemization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112391438A reveals a novel enzymatic deracemization process for high-purity L-glufosinate-ammonium, offering significant supply chain and cost advantages.
Patent CN104557911A details a chemo-enzymatic route for (R)-praziquantel. This method ensures high optical purity and significant cost reduction in anthelmintic drug manufacturing.
Patent CN102660624A reveals a dual-bacteria catalytic method for high-purity chiral alpha-hydroxy acids, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN109609582A reveals microbial deracemization for L-glufosinate-ammonium. Achieve high purity and cost reduction in herbicide manufacturing with scalable biocatalysis.
Patent CN109609582B reveals a novel microbial deracemization route for L-glufosinate-ammonium, offering superior purity and cost-effective supply chain solutions.
Patent CN107502647B reveals a novel enzymatic deracemization route for L-glufosinate-ammonium, offering superior optical purity and cost-effective manufacturing for global agrochemical supply chains.
Patent CN111321193B details a novel enzymatic deracemization for high-purity L-glufosinate. Discover cost-effective biocatalytic solutions for herbicide manufacturing.
Patent CN105237532A reveals enzymatic route for L-praziquantel. Offers high optical purity and greener manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN107502647A reveals high-purity L-glufosinate-ammonium production via enzymatic deracemization, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.